news2Introducing GW PharmaceuticalsDiscover more about GW...Meeting patients' needsPatient information can be found here....World leading scienceMore about our scientific collaborations...A valuable ...
http://www.gwpharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
Contact for GW Pharmaceuticals - DELETED
Lee Berry
Porton D●●●●●●●●nce Park
Sal●●●ury , Wiltshire, SP4 0JQ
GB
View this contact
GW Pharma
Chris Smith
Porton D●●●●●●●●nce Park
Sal●●●ury , Wiltshire, SP4 0JQ
GB
View this contact
NetNames Hostmaster
Domain Administrator
3rd Floo●●●●●●●●ro House
241 Boro●●●●●●●●h Street
Bo●●gh , London, SE1 1GA
GB
View this contact
BUY YOUR DOMAIN
22
YEARS
5
MONTHS
14
DAYS
ASCIO TECHNOLOGIES, INC.
WHOIS : whois.ascio.com
REFERRED : http://www.ascio.com
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
23
SITE IP
185.19.14.34
LOAD TIME
0 sec
SCORE
6.2
GWPharma - Welcome | gwpharma.com Reviews
https://gwpharma.com
news2Introducing GW PharmaceuticalsDiscover more about GW...Meeting patients' needsPatient information can be found here....World leading scienceMore about our scientific collaborations...A valuable ...
gwpharma.com
GWPharma - Media
http://www.gwpharma.com/media.aspx
Welcome to the media section of the GW website, dedicated to providing useful information for press enquiries. This section contains current and previous press releases, notes to editors, image library and media contact information. For a dedicated page relating to Sativex click here. GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress. London, UK, 9 August 2016: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, GW, the Company or the Gr.
GWPharma - About Us
http://www.gwpharma.com/about-us.aspx
Our vision. is to be the global leaders in prescription cannabinoid medicines, through the rapid cost-effective development of pharmaceutical products which address clear unmet needs. GW is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of MS spasticity and cancer pain, and Epidiolex for the treatment of childhood epilepsy. GW’s focus is to develop novel prescription medicines which make a real difference to the lives of patients.
GWPharma - Disclosure & Disclaimer
http://www.gwpharma.com/Disclosure-and-Disclaimer.aspx
GW Pharmaceuticals plc is a public limited company incorporated and registered in England and Wales. Content and information provided by third parties other than the Company is identified clearly where it appears. The Company publishes this content as supplied to it and is not responsible for its accuracy or timeliness. You must take appropriate steps to verify this information before acting upon it. The information contained in this Website is not (and should not be construed as) a recommendation, invit...
GWPharma - Welcome
http://www.gwpharma.com/default.aspx
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Sativex
http://www.gwpharma.com/Sativex.aspx
Is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain. Has now been launched in 15 countries (including the UK, Spain, Italy and Germany) and approved in a further 12. UK Information for Physicians and Patients. Information regarding MS trials, general spasticity information and patient organisations. Information for physicians on the availability of Sativex in different countries.
TOTAL PAGES IN THIS WEBSITE
13
Pure Analytics - Resources
http://www.pureanalytics.net/resources
Mold and Fungus Screen. Elevate Your Grow Program. Cannabis testing discussion forum, for the latest on the cannabis testing industry and upcoming Pure Analytics events. Useful Informational Web Sites:. Patient Sample Drop-off Locations. 6771 Sebastopol Ave. #100, Sebastopol CA. Hours: M-Sat 11am-7pm, Sun 12pm-7pm. Phone: 707.823.4206. Web: www.peaceinmedicine.org. 1190 Coleman Ave, San Jose CA. Phone: 408.320.0230. Web: www.southbayhealingcenter.org. 952 Mission St, San Francisco. Web Hosting by Yahoo!
Arthritis research funded by Medical Research Scotland
http://www.medicalresearchscotland.com/arthritis.htm
Research into all diseases. Patron HRH The Princess Royal. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Arthritis and inflammatory diseases. Last Updated September 23rd 2014. Diseases and disease mechanisms. Awards in the past 20 years. The following are some of the awards we made for research into arthritis and a range of other inflammatory or immune disorders. The cannabinoid-...
medicalresearchscotland.org.uk
Arthritis research funded by Medical Research Scotland
http://medicalresearchscotland.org.uk/arthritis.htm
Research into all diseases. Patron HRH The Princess Royal. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Arthritis and inflammatory diseases. Last Updated September 23rd 2014. Diseases and disease mechanisms. Awards in the past 20 years. The following are some of the awards we made for research into arthritis and a range of other inflammatory or immune disorders. The cannabinoid-...
Pure Analytics - Resources
http://www.highthcstrain.com/resources
Mold and Fungus Screen. Elevate Your Grow Program. Cannabis testing discussion forum, for the latest on the cannabis testing industry and upcoming Pure Analytics events. Useful Informational Web Sites:. Patient Sample Drop-off Locations. 6771 Sebastopol Ave. #100, Sebastopol CA. Hours: M-Sat 11am-7pm, Sun 12pm-7pm. Phone: 707.823.4206. Web: www.peaceinmedicine.org. 1190 Coleman Ave, San Jose CA. Phone: 408.320.0230. Web: www.southbayhealingcenter.org. 952 Mission St, San Francisco. Web Hosting by Yahoo!
Research in Aberdeen funded by Medical Research Scotland
http://shert.co.uk/resabdn.htm
Research into all diseases. Patron HRH The Princess Royal. The research we fund. We support research across all the fields of clinical, biomedical, physical or engineering sciences related to medicine. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Last updated September 23rd 2014. Awarded during 2013-14 included the following to Aberdeen University:. During her PhD Studentship.
Pure Analytics - Resources
http://www.thccannabistest.com/resources
Mold and Fungus Screen. Elevate Your Grow Program. Cannabis testing discussion forum, for the latest on the cannabis testing industry and upcoming Pure Analytics events. Useful Informational Web Sites:. Patient Sample Drop-off Locations. 6771 Sebastopol Ave. #100, Sebastopol CA. Hours: M-Sat 11am-7pm, Sun 12pm-7pm. Phone: 707.823.4206. Web: www.peaceinmedicine.org. 1190 Coleman Ave, San Jose CA. Phone: 408.320.0230. Web: www.southbayhealingcenter.org. 952 Mission St, San Francisco. Web Hosting by Yahoo!
Pure Analytics - Resources
http://www.cannabissafetylab.com/resources
Mold and Fungus Screen. Elevate Your Grow Program. Cannabis testing discussion forum, for the latest on the cannabis testing industry and upcoming Pure Analytics events. Useful Informational Web Sites:. Patient Sample Drop-off Locations. 6771 Sebastopol Ave. #100, Sebastopol CA. Hours: M-Sat 11am-7pm, Sun 12pm-7pm. Phone: 707.823.4206. Web: www.peaceinmedicine.org. 1190 Coleman Ave, San Jose CA. Phone: 408.320.0230. Web: www.southbayhealingcenter.org. 952 Mission St, San Francisco. Web Hosting by Yahoo!
Research in Aberdeen funded by Medical Research Scotland
http://www.medicalresearchscotland.org/resabdn.htm
Research into all diseases. Patron HRH The Princess Royal. The research we fund. We support research across all the fields of clinical, biomedical, physical or engineering sciences related to medicine. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Last updated September 23rd 2014. Awarded during 2013-14 included the following to Aberdeen University:. During her PhD Studentship.
Neurological research funded by Medical Research Scotland
http://www.medicalresearchscotland.com/neuro.htm
Research into all diseases. Patron HRH The Princess Royal. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Last Updated September 23rd 2014. Diseases and disease mechanisms. Awards in the past 20 years. The following are some of the awards we made for research into diseases affecting the brain and neurological system, including stroke. During her PhD Studentship. The cannabinoid-1 ...
Arthritis research funded by Medical Research Scotland
http://www.medicalresearchscotland.org/arthritis.htm
Research into all diseases. Patron HRH The Princess Royal. Arthritis and inflammatory diseases. Cardiac and vascular diseases. Neurological disorders (including Stroke). Medical Research Scotland is a. Member of the Association of. Arthritis and inflammatory diseases. Last Updated September 23rd 2014. Diseases and disease mechanisms. Awards in the past 20 years. The following are some of the awards we made for research into arthritis and a range of other inflammatory or immune disorders. The cannabinoid-...
TOTAL LINKS TO THIS WEBSITE
23
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
Home | GW Pharmaceuticals, plc
Skip to main content. We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK. Epilepsy Patients and Caregivers. GW’s vision is to be the global leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which address clear unmet needs. Mar 15, 2018. Mar 05, 2018. Feb 27, 2018. GW Pharmaceuticals R...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
The domain www.gwpharma.biz is registered by NetNames
The domain name www.gwpharma.biz. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
The domain www.gwpharmaceuticals.biz is registered by NetNames
The domain name www.gwpharmaceuticals.biz. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
IIS7
Offering Business Leaders A Unique Opportunity. The Heritage Company offers a unique and fulfilling job opportunity. As a division of Good Will Publishers, Incorporated, Heritage Company reaches out to the families grieving the loss of a loved one. With our unique sponsorship marketing. Method, we enable civic minded business leaders to share their condolences with members of their community by providing the family a beautiful and permanent keepsake volume entitled.
